Cargando…
Suppression of Cisplatin-Induced Hepatic Injury in Rats Through Alarmin High-Mobility Group Box-1 Pathway by Ganoderma lucidum: Theoretical and Experimental Study
PURPOSE: Drug-induced liver injury (DILI) is the most common cause of acute liver failure. The aim of this study was to investigate the molecular mechanisms by which Ganoderma lucidum mushroom (GLM) may ameliorate cisplatin (CP)-induced hepatotoxicity theoretically and experimentally. MATERIALS AND...
Autores principales: | Hassan, Hanan M, Al-Wahaibi, Lamya H, Elmorsy, Mohammed A, Mahran, Yasmen F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296982/ https://www.ncbi.nlm.nih.gov/pubmed/32606602 http://dx.doi.org/10.2147/DDDT.S249093 |
Ejemplares similares
-
Ganoderma lucidum Prevents Cisplatin-Induced Nephrotoxicity through Inhibition of Epidermal Growth Factor Receptor Signaling and Autophagy-Mediated Apoptosis
por: Mahran, Yasmen F., et al.
Publicado: (2020) -
Triterpenoids from the spores of Ganoderma lucidum
por: Ma, Bingji, et al.
Publicado: (2011) -
Polysaccharide of Ganoderma lucidum Ameliorates Cachectic Myopathy Induced by the Combination Cisplatin plus Docetaxel in Mice
por: Wu, Sung-Yu, et al.
Publicado: (2023) -
The Innovation Research on the Extraction Technology of Ganoderma Lucidum
por: Liang, Chen
Publicado: (2012) -
Ganoderma lucidum and Professor Zhi-Bin Lin
por: Su, Ding-Feng, et al.
Publicado: (2012)